Agilent Technologies Gross Margin 2010-2025 | A

Current and historical gross margin for Agilent Technologies (A) over the last 10 years. The current gross profit margin for Agilent Technologies as of April 30, 2025 is %.
Agilent Technologies Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-04-30 $6.63B $3.54B 53.35%
2025-01-31 $6.53B $3.53B 53.97%
2024-10-31 $6.51B $3.54B 54.30%
2024-07-31 $6.50B $3.53B 54.39%
2024-04-30 $6.59B $3.34B 50.63%
2024-01-31 $6.74B $3.41B 50.56%
2023-10-31 $6.83B $3.47B 50.71%
2023-07-31 $6.99B $3.56B 50.93%
2023-04-30 $7.04B $3.84B 54.59%
2023-01-31 $6.93B $3.78B 54.55%
2022-10-31 $6.85B $3.72B 54.35%
2022-07-31 $6.66B $3.61B 54.21%
2022-04-30 $6.53B $3.52B 53.98%
2022-01-31 $6.45B $3.48B 53.98%
2021-10-31 $6.32B $3.41B 53.92%
2021-07-31 $6.14B $3.30B 53.65%
2021-04-30 $5.82B $3.11B 53.50%
2021-01-31 $5.53B $2.95B 53.38%
2020-10-31 $5.34B $2.84B 53.14%
2020-07-31 $5.22B $2.79B 53.34%
2020-04-30 $5.24B $2.81B 53.65%
2020-01-31 $5.24B $2.82B 53.88%
2019-10-31 $5.16B $2.81B 54.33%
2019-07-31 $5.09B $2.78B 54.54%
2019-04-30 $5.02B $2.74B 54.65%
2019-01-31 $4.99B $2.72B 54.48%
2018-10-31 $4.91B $2.68B 54.54%
2018-07-31 $4.81B $2.61B 54.25%
2018-04-30 $4.72B $2.55B 53.94%
2018-01-31 $4.62B $2.50B 54.05%
2017-10-31 $4.47B $2.40B 53.64%
2017-07-31 $4.39B $2.35B 53.48%
2017-04-30 $4.32B $2.30B 53.10%
2017-01-31 $4.24B $2.23B 52.68%
2016-10-31 $4.20B $2.20B 52.28%
2016-07-31 $4.13B $2.14B 51.96%
2016-04-30 $4.10B $2.12B 51.64%
2016-01-31 $4.04B $2.07B 51.11%
2015-10-31 $4.04B $2.04B 50.54%
2015-07-31 $4.81B $2.40B 49.98%
2015-04-30 $4.80B $2.39B 49.80%
2015-01-31 $4.83B $2.40B 49.65%
2014-10-31 $4.81B $2.39B 49.77%
2014-07-31 $4.72B $2.41B 50.92%
2014-04-30 $5.37B $2.76B 51.42%
2014-01-31 $6.11B $3.17B 51.80%
2013-10-31 $6.78B $3.54B 52.12%
2013-07-31 $6.83B $3.55B 51.95%
2013-04-30 $6.90B $3.58B 51.91%
2013-01-31 $6.90B $3.61B 52.30%
2012-10-31 $6.86B $3.60B 52.55%
2012-07-31 $6.82B $3.60B 52.84%
2012-04-30 $6.79B $3.61B 53.12%
2012-01-31 $6.73B $3.59B 53.29%
2011-10-31 $6.62B $3.53B 53.35%
2011-07-31 $6.46B $3.44B 53.26%
2011-04-30 $6.16B $3.28B 53.20%
2011-01-31 $5.75B $3.09B 53.67%
2010-10-31 $5.44B $2.93B 53.82%
2010-07-31 $5.04B $2.73B 54.22%
2010-04-30 $4.71B $2.54B 54.04%
2010-01-31 $4.53B $2.36B 52.19%
2009-10-31 $4.48B $2.29B 51.15%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $33.278B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.741B 26.94
Boston Scientific (BSX) United States $155.895B 37.18
Stryker (SYK) United States $147.123B 29.95
EssilorLuxottica (ESLOY) France $145.891B 0.00
Medtronic (MDT) Ireland $116.772B 16.47
Lonza Group Ag (LZAGY) Switzerland $49.160B 0.00
Haleon (HLN) United Kingdom $44.031B 25.15
ResMed (RMD) United States $42.217B 30.19
GE HealthCare Technologies (GEHC) United States $33.398B 15.70
Terumo (TRUMY) Japan $27.302B 32.35
Koninklijke Philips (PHG) Netherlands $26.423B 17.48
Insulet (PODD) United States $23.078B 77.32
Zimmer Biomet Holdings (ZBH) United States $20.685B 13.17
Smith & Nephew SNATS (SNN) United Kingdom $16.192B 0.00
Baxter (BAX) United States $12.250B 9.46
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $7.714B 28.33
Lantheus Holdings (LNTH) United States $4.023B 10.88
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.400B 23.79
Perrigo (PRGO) Ireland $3.224B 8.05
Prestige Consumer Healthcare (PBH) United States $3.221B 14.29
ICU Medical (ICUI) United States $3.005B 20.46
Haemonetics (HAE) United States $2.601B 11.61
LeMaitre Vascular (LMAT) United States $2.183B 46.82
Acuren (TIC) United States $2.054B 0.00
Curaleaf Holdings (CURLF) Canada $1.918B 0.00
Green Thumb Industries (GTBIF) United States $1.804B 77.48
AtriCure (ATRC) United States $1.776B 0.00
QuidelOrtho (QDEL) United States $1.742B 10.97
Phibro Animal Health (PAHC) United States $1.279B 16.35
AdaptHealth (AHCO) United States $1.261B 17.92
Tilray Brands (TLRY) Canada $1.222B 0.00
Neogen (NEOG) United States $1.216B 19.31
BioLife Solutions (BLFS) United States $1.201B 2508.00
Valneva SE (VALN) France $0.952B 0.00
InMode (INMD) Israel $0.898B 8.31
Kestra Medical Technologies (KMTS) United States $0.876B 0.00
Verano Holdings (VRNOF) United States $0.622B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.609B 0.00
SNDL (SNDL) Canada $0.589B 0.00
Cresco Labs (CRLBF) United States $0.587B 0.00
ZimVie (ZIMV) United States $0.534B 20.58
Surmodics (SRDX) United States $0.516B 0.00
Evolus (EOLS) United States $0.480B 0.00
VAREX IMAGING (VREX) United States $0.471B 16.20
CeriBell (CBLL) United States $0.428B 0.00
Owens & Minor (OMI) United States $0.392B 3.48
Sanuwave Health (SNWV) United States $0.354B 0.00
Capricor Therapeutics (CAPR) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Omeros (OMER) United States $0.305B 0.00
TerrAscend (TSNDF) Canada $0.303B 0.00
Canopy Growth (CGC) Canada $0.297B 0.00
Brainsway (BWAY) Israel $0.283B 57.65
Viemed Healthcare (VMD) United States $0.273B 20.74
High Tide (HITI) Canada $0.273B 0.00
Sanara MedTech (SMTI) United States $0.272B 0.00
Aurora Cannabis (ACB) Canada $0.270B 0.00
Vireo Growth (VREOF) United States $0.231B 0.00
Cerus (CERS) United States $0.230B 0.00
Quanterix (QTRX) United States $0.225B 0.00
Exagen (XGN) United States $0.220B 0.00
Organigram Global (OGI) Canada $0.210B 0.00
OraSure Technologies (OSUR) United States $0.209B 0.00
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.184B 15.37
FitLife Brands (FTLF) United States $0.155B 19.10
Biote (BTMD) United States $0.149B 4.95
Jushi Holdings (JUSHF) United States $0.131B 0.00
Fonar (FONR) United States $0.094B 12.17
Quipt Home Medical (QIPT) United States $0.092B 0.00
MacroGenics (MGNX) United States $0.091B 0.00
Jin Medical (ZJYL) China $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.084B 0.00
Apyx Medical (APYX) United States $0.078B 0.00
Safety Shot (SHOT) United States $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.054B 31.47
Cytosorbents (CTSO) United States $0.053B 0.00
Veru (VERU) United States $0.052B 0.00
Zynex (ZYXI) United States $0.046B 0.00
Nephros (NEPH) United States $0.043B 33.50
Rockwell Medical (RMTI) United States $0.040B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 14.82
Trinity Biotech (TRIB) Ireland $0.028B 0.00
Senestech (SNES) United States $0.022B 0.00
INLIF (INLF) $0.017B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00